Patients and lay people in Japan now form one of the major groups that support current drug development, safety, supply, and regulatory affairs. This session will discuss recent change and the significant effect of the patient voice on drug policy and the progress of the amendment of the Pharmaceutical Affairs Law.

Learning Objectives:
Recognize recent change and the significant effect of the patient voice on drug policy and the legal amendment
Discuss some inconsistency and even slight tensions among safety oriented groups and drug lag oriented groups
Discuss the future direction of the amendment of Pharmaceutical Affairs Law.